Navigation Links
Researchers Evaluate Computer-based Treatment for People with Schizophrenia
Date:6/27/2012

SAN FRANCISCO, June 27, 2012 /PRNewswire/ -- Researchers at San Francisco-based Brain Plasticity, Inc. (BPI) have begun a multi-center study to evaluate the effects of a computerized, brain-plasticity-based program designed to address the cognitive issues associated with schizophrenia.  The clinical trial, e-CAeSAR (Evaluation of a Cognitively Adaptive e-treatment in Schizophrenia-diagnosed Adults:  A Remediation-based Approach), is being funded by the National Institute of Mental Health (NIMH) and will be conducted at eleven research centers in the U.S. in collaboration with experienced investigators from the Schizophrenia Trials Network (STN).

Cognitive impairment is a devastating component of schizophrenia that affects virtually all persons who are diagnosed.  The NIMH estimates that nearly 40 percent ($44 billion) of schizophrenia's total cost involves lost time from work for patients and care providers, and places high demands on social services.  This makes schizophrenia the most costly mental illness in the United States.

The "e-CAeSAR" trial is the first time neuroscientists will work with U.S. Food and Drug Administration representatives to evaluate Brain Plasticity's program.  Pharmaceutical companies have tested drugs in development to alleviate the cognitive symptoms of schizophrenia; thus far none have been FDA-approved as efficacious. 

"Cognitive impairment in schizophrenia sorely needs attention, yet there are no FDA-approved treatments for this devastating aspect of the illness," notes Dr. Richard Keefe of the Schizophrenia Trials Network (STN).  These cognitive impairments can limit the ability of persons with schizophrenia to process new information accurately and quickly, make effective decisions and remember key information.  Coupled together, these symptoms can severely impair patients' abilities to perform everyday activities, live independently, gain employment and sustain social relationships. It is commonly believed that the most significant symptoms of schizophrenia are delusions and/or hallucinations, yet these represent only a fraction of the symptoms.

"We are honored to work with world-renowned researchers who are part of the Schizophrenia Trials Network.  We hope that our efforts encourage other scientists to develop and study new cognitive treatments to support persons with schizophrenia and their families," states BPI Chief Operating Officer Dr. Henry Mahncke.

"We are excited to participate in this long-awaited, much-needed seminal trial of cognitive remediation for individuals with schizophrenia. Cognitive remediation is a potential breakthrough treatment that along with more traditional pharmaceutical and psychotherapeutic modalities may significantly impact the lives of those living with schizophrenia, their families and society as a whole, said Jennifer Hoblyn, MD, MPH, who directs Inpatient Mental Health Services at the Veterans Affairs Medical Center in Palo Alto, CA., an investigator in the e-CAeSAR study. 

About Brain Plasticity Incorporated

Brain Plasticity, Inc., was founded in 2009 to support the rapid development and evaluation of innovative neuroscience-based brain health solutions. For more information, visit www.brainplasticity.com or contact Henry Mahncke, PhD, at 415.394.3107.

Media Contact:

Peggy Jara

Harden Communications Partners

510-635-4150

pjara@hardenpartners.com


'/>"/>
SOURCE Brain Plasticity, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Rethinking Research Ethics: Carnegie Mellon and McGill Researchers Challenge Post-marketing Trial Practices
2. Van Andel Institute Researchers Find Potential Drug Target For Aggressive Form Of Lymphoma
3. EvaluatePharma Names Debbie Paul CEO, Americas to Lead Growth in Key Region
4. Study Finds Utilizing Integrated Medical and Pharmacy Data Improves Ability to Forecast Use of High-cost Specialty Treatments
5. Aethlon Medical Note: An Unprecedented Data Point, The Single-Treatment Capture of Hepatitis C Virus (HCV) by the Aethlon Hemopurifier®
6. Onyx Pharmaceuticals Announces FDA Advisory Committee to Review Carfilzomib for the Treatment of Patients with Relapsed and Refractory Multiple Myeloma
7. Accuray Launches First Study to Compare CyberKnife® SBRT to Surgery and IMRT for Treatment of Early-Stage Prostate Cancer
8. Elekta, pioneer in treatment of cancer in brain disorders, to Move North America Headquarters to Atlanta
9. Ampio Awarded US and Canadian Patents that will Bolster the Commercialization of Optina™ for the treatment of Diabetic Macular Edema (DME)
10. National Patient Advocate Foundation Praises Signing of the Delaware Cancer Treatment Access Act into Law
11. Zogenix Submits New Drug Application (NDA) to U.S. Food and Drug Administration (FDA) for Zohydro™ for Treatment of Chronic Pain
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/23/2017)... Research and Markets has announced the addition of the "Global ... Repair Procedure By Technique, By Region, By Country (2016-2021)" report ... ... a CAGR of 13.35% during 2016-2021 The strong growth ... in population with heart disease and rising advances in minimally invasive ...
(Date:3/23/2017)... INDIANAPOLIS , March 23, 2017  Eli Lilly ... William Sansum Diabetes Center have established a research collaboration ... diabetes through enhanced research, education and care. ... bears a disproportionate weight on Latino families in ... Kerr , M.D., FRCPE, director of Innovation and Research ...
(Date:3/23/2017)... -- Summary Global Markets ... Primary Hyperoxaluria - Pipeline Review, H1 2017, provides ... System And Sex Hormones) pipeline landscape. Primary ... kidney and bladder stones. It results from the ... blood in the urine, pain when urinating, fever, ...
Breaking Medicine Technology:
(Date:3/24/2017)... ... March 24, 2017 , ... In ... innovative EcoQube Frame vertical micro-veggies garden on Kickstarter . Surpassing the $100,000 ... – with nearly 2,000 consumers (and counting) already backing the campaign. , ...
(Date:3/24/2017)... ... 2017 , ... The law firm of Enea, Scanlan & Sirignano, LLP, ... resident Lauren C. Enea has joined the firm as an associate attorney. Ms. Enea, ... in elder law, Medicaid planning and applications, and Wills, Trusts and Estates. Samantha ...
(Date:3/24/2017)... ... March 24, 2017 , ... Judy Buchanan, co-owner of Serenity ... MD. Judy says, “I am passionate about sharing Reiki as a holistic, complementary ... and challenging time.” , A Certified Medical Reiki™ Master trained by Raven Keys ...
(Date:3/24/2017)... ... March 24, 2017 , ... “The Communion of Saints: ... of God in congregations across the United States. “The Communion of Saints” ... 1964 who has served congregations in seven states throughout his long career of ...
(Date:3/23/2017)... ... , ... The physicians of KSF Orthopaedic Center PA are proud to announce ... is located at 2255 E. Mossy Oaks Rd., Suite 440, Spring, Texas 77389 inside ... patients living in the north Houston area (The Woodlands, Conroe, Magnolia, Kingwood, Humble) with ...
Breaking Medicine News(10 mins):